Bridgebio Pharma, Inc. · NASDAQ:BBIO
BlackRock, Inc.'s stake in Bridgebio Pharma, Inc. fell to 4.96% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc.'s stake in Bridgebio Pharma, Inc. fell to 4.96%, 9,733,762 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).
- Stake
- 4.96%
- Shares
- 9,733,762
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.96% | 9,733,762 |